Atrial Fibrillation. Atrial fibrillation and flutter
Conditions
Interventions
Intervention 1: Intervention group: 2000 µg Selenium supplementation in the prime solution during cardiopulmonary bypass. Intervention 2: Control group: Normal saline in the prime solution during card
Treatment - Drugs
Placebo
Intervention group: 2000 µg Selenium supplementation in the prime solution during cardiopulmonary bypass
Control group: Normal saline in the prime solution during cardiopulmonary bypass
Sponsors
Vice chancellor for research,Mazandaran University of Medical Science
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Candidate for CABG; non-emergency surgery; use of cardiopulmonary bypass pump during surgery; no history of cardiac tachyarrhythmia before surgery; hemodynamic stability ( heart beat 50-110, MAP>50); between 35 to 75 years old. Exclusion criteria: Heart failure (EF 0.1 µg/kg/min dopamine and dobutamine > 10µg/kg/min).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atrial Fibrillation. Timepoint: Immediately after surgery and on the first,second and third day after operation and transferring to ICU. Method of measurement: Saadat Monitoring Devices. | — |
Secondary
| Measure | Time frame |
|---|---|
| Other arrhythmias. Timepoint: Immediately after the surgery and on the first, second or third day after operation and transferring to ICU. Method of measurement: saadat monitoring devices.;Hs-CRP serum levels. Timepoint: Befor the surgery,after bypass and on the first day hospitalization in ICU. Method of measurement: VIDZS devices And VIDZS Kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Enayati, MD
Mazandaran University of Medical Sciences
Outcome results
None listed